Product record
Ayurvedic-labelled products found to contain allopathic drugs: Maharashtra FDA rows
Last checked 10 October 2026
Maharashtra FDA's table, as of 9 Oct 2026, lists four products sold as ayurvedic that contained undeclared drugs: paracetamol and diclofenac, metformin, famotidine, and mercury. Each is one finding on one product, not a finding about a licensed brand.
- Classification
- Declared spurious (fake or misbranded)
- Decided by
- Maharashtra Food and Drug Administration
- Reference
- Maharashtra FDA NSQ alerts table, as read on 9 Oct 2026
- Latest action
- 9 October 2026
- Last checked
- 10 October 2026
Photo: Contemporary Ayurveda (156350019).jpeg by Hans Vivek (CC0). All photo credits.
Maharashtra FDA: not of standard quality (NSQ) alerts table
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Paracetamol and diclofenac
- A product of Gurudarshan Ayurvedic Dawakhana, as printed in the table
- Metformin
- 'Fasttake Ayurvedic Churn Sugar Safe'
- Famotidine
- A product printed as Vanganga in the table
- Mercury
- 'Mulpeshi Vikas', printed as unlabelled
- Maker
- Where the table prints a maker as unlabelled or purported, we do not name one
Maharashtra FDA publishes a table of products declared not of standard quality. Its rows for products sold as ayurvedic include four that contained undeclared drugs, according to the table as read on 9 Oct 2026. The table has 190 rows, about 20 of them for ayurvedic, siddha and unani products.
The four rows are a product of Gurudarshan Ayurvedic Dawakhana with paracetamol and diclofenac; 'Fasttake Ayurvedic Churn Sugar Safe' with metformin; a product printed as Vanganga with famotidine; and an unlabelled 'Mulpeshi Vikas' with mercury.
The table gives the maker as printed on the sample. Where it prints the maker as unlabelled or purported, the product cannot be attributed to a licensed company, and we do not do so. The table is our only identification of these products, and we have not verified whether the printed names belong to licensed firms. These are findings on named products. They are not a finding about ayurvedic medicines in general.
What this means for you
Do not link these to a licensed brand
The table prints the maker as it appears on the sample. An unlabelled or purported product cannot be traced to any licensed ayurvedic company.
Four rows, not a pattern
Four rows in a table of 190 are too few to say anything about products in general. We make no claim beyond the named rows.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Common questions
Does this mean ayurvedic medicines contain allopathic drugs?
No. Four rows in a table of 190 concern products sold as ayurvedic. They are named findings, not a finding about ayurvedic medicines or any licensed brand.
Official sources and primary records
- Maharashtra FDA: not of standard quality (NSQ) alerts tableRegulatorMaharashtra Food and Drug Administration · 9 October 2026